The Business Research Company’s Drug Discovery Technologies Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Drug Discovery Technologies Global Market Report 2023 evaluates drug discovery technologies market size, growth rate, drivers, trends, and major companies. The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. Request A Free Sample Of The Report (Includes Graphs And Tables): https://www.thebusinessresearchcompany.com/sample.aspx?id=12715&type=smp The global drug discovery technologies market is expected to grow from $59.86 billion in 2022 to $66.08 billion in 2023 at a compound annual growth rate (CAGR) of 10.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The drug discovery technologies market is expected to reach $97.09 billion in 2027 at a CAGR of 10.1%. The rising prevalence of acute and chronic diseases is expected to propel the drug discovery technologies market going forward. Chronic diseases last one year or more and require ongoing medical attention. Innovation in drug discovery technologies and drug development has brought many new treatments for chronic diseases. Integrating new and powerful emerging technologies, including digital health tools, AI, and machine learning, throughout the drug R&D process offers opportunities to address critical barriers and streamline clinical trials for prevalent chronic diseases. For instance, in May 2023, according to The United Nations (UN), a US-based intergovernmental organization to promote international cooperation and maintain international peace and security, Chronic diseases were responsible for seven out of 10 deaths in the US, killing more than 1.7 million Americans annually. Therefore, the rising prevalence of acute and chronic diseases will drive the drug discovery technologies market. Get More Information On The Drug Discovery Technologies Market Report: https://www.thebusinessresearchcompany.com/report/drug-discovery-technologies-global-market-report The drug discovery technologies market segments in the report are: 1) By Technology: High Throughput Screening, Genomics, Nanotechnology, Bioinformatics, Combinational Chemistry, Pharmacogenomics, Biochips, Bioanalytical Instruments, Ribonucleic Acid Interface (RNAI) 2) By Drug Type: Small Molecule Drugs, Biologic Drugs 3) By Disease Application: Cancer Diseases, Immunological Diseases, Neurological Diseases, Cardiovascular Diseases, Other Disease Applications 4) By End-User: Pharmaceutical Companies, Biopharmaceutical Companies, Biotechnology Companies, Research Institutes, Other End-Users The table of contents in TBRC’s drug discovery technologies market report includes: 1. Executive Summary 2. Drug Discovery Technologies Market Characteristics 3. Drug Discovery Technologies Market Trends And Strategies 4. Drug Discovery Technologies Market - Macro Economic Scenario 5.1. Global Drug Discovery Technologies Market Drivers and Restraints 6. Drug Discovery Technologies Market Segmentation 7. Drug Discovery Technologies Market Regional And Country Analysis . . . 27. Brazil Drug Discovery Technologies Market 28. Middle East Drug Discovery Technologies Market 29. Africa Drug Discovery Technologies Market Learn About Us: The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: info@tbrc.info Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info Facebook: https://www.facebook.com/TheBusinessResearchCompany YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Blog: https://blog.tbrc.info/ Healthcare Blog: https://healthcareresearchreports.com/ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model